JP2021529787A5 - - Google Patents

Info

Publication number
JP2021529787A5
JP2021529787A5 JP2020573468A JP2020573468A JP2021529787A5 JP 2021529787 A5 JP2021529787 A5 JP 2021529787A5 JP 2020573468 A JP2020573468 A JP 2020573468A JP 2020573468 A JP2020573468 A JP 2020573468A JP 2021529787 A5 JP2021529787 A5 JP 2021529787A5
Authority
JP
Japan
Prior art keywords
selectively
acid
drugs
parasites
graft
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020573468A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021529787A (ja
JP7296644B2 (ja
Filing date
Publication date
Priority claimed from CN201810698033.6A external-priority patent/CN108743938B/zh
Priority claimed from CN201810700708.6A external-priority patent/CN109078180B/zh
Application filed filed Critical
Priority claimed from PCT/CN2019/093607 external-priority patent/WO2020001596A1/zh
Publication of JP2021529787A publication Critical patent/JP2021529787A/ja
Publication of JP2021529787A5 publication Critical patent/JP2021529787A5/ja
Application granted granted Critical
Publication of JP7296644B2 publication Critical patent/JP7296644B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020573468A 2018-06-29 2019-06-28 免疫応答を強化するための複合物の調製方法 Active JP7296644B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
CN201810700708.6 2018-06-29
CN201810698033.6A CN108743938B (zh) 2018-06-29 2018-06-29 用于增强免疫响应的复合物的制备方法
CN201810698033.6 2018-06-29
CN201810700708.6A CN109078180B (zh) 2018-06-29 2018-06-29 用于增强免疫响应的复合物
PCT/CN2019/093607 WO2020001596A1 (zh) 2018-06-29 2019-06-28 用于增强免疫响应的复合物的制备方法

Publications (3)

Publication Number Publication Date
JP2021529787A JP2021529787A (ja) 2021-11-04
JP2021529787A5 true JP2021529787A5 (cg-RX-API-DMAC7.html) 2022-06-22
JP7296644B2 JP7296644B2 (ja) 2023-06-23

Family

ID=68984509

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020573468A Active JP7296644B2 (ja) 2018-06-29 2019-06-28 免疫応答を強化するための複合物の調製方法
JP2020573491A Active JP7366434B2 (ja) 2018-06-29 2019-06-28 免疫応答を強化するための複合物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2020573491A Active JP7366434B2 (ja) 2018-06-29 2019-06-28 免疫応答を強化するための複合物

Country Status (11)

Country Link
US (2) US12178871B2 (cg-RX-API-DMAC7.html)
EP (2) EP3818990A4 (cg-RX-API-DMAC7.html)
JP (2) JP7296644B2 (cg-RX-API-DMAC7.html)
KR (2) KR102631084B1 (cg-RX-API-DMAC7.html)
AU (1) AU2019296320B2 (cg-RX-API-DMAC7.html)
BR (1) BR112020026976A2 (cg-RX-API-DMAC7.html)
CA (2) CA3105281A1 (cg-RX-API-DMAC7.html)
MX (1) MX2021000002A (cg-RX-API-DMAC7.html)
SG (2) SG11202013185VA (cg-RX-API-DMAC7.html)
WO (2) WO2020001596A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA202100026B (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7296644B2 (ja) 2018-06-29 2023-06-23 信福(北京)医▲薬▼科技有限公司 免疫応答を強化するための複合物の調製方法
WO2025076078A1 (en) * 2023-10-03 2025-04-10 The General Hospital Corporation Methods of central nervous system administration of compositions comprising a cell therapy and dimethyl sulfoxide

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1056315C (zh) 1993-05-31 2000-09-13 林海祥 聚肌胞复合物免疫佐剂及含有该佐剂的疫苗
ES2259914B1 (es) 2005-03-14 2007-06-16 Advanced In Vitro Cell Technologies, S.L. Nanoparticulas de quitosano y polietilenglicol como sistema de administracion de moleculas biologicamente activas.
CN103405762A (zh) * 2005-06-08 2013-11-27 依生生物制药(新加坡)私人有限公司 以聚肌苷酸-聚胞苷酸为主的佐剂
KR101203401B1 (ko) 2005-06-08 2012-11-22 이쉥 바이오파마(싱가포르)피티이 리미티드 폴리이노신산-폴리시티딜산-기초 보조제
US20070166239A1 (en) 2006-01-13 2007-07-19 Haixiang Lin Mucosal immunogenic substances comprising a polyinosinic acid - polycytidilic acid based adjuvant
US20070166800A1 (en) 2006-01-13 2007-07-19 Haixiang Lin Immunogenic substances comprising a polyinosinic acid-polycytidilic acid based adjuvant
CN101134014A (zh) 2007-09-19 2008-03-05 天津大学 带有表面涂层的硫酸钙串珠植入型局部释药体系及制备方法
CN101293933B (zh) 2008-06-17 2011-05-04 浙江大学 聚乙二醇修饰壳寡糖脂肪酸嫁接物及制备方法和应用
CN102318740B (zh) 2011-07-15 2012-11-21 山东省农业科学院畜牧兽医研究所 复合氨基酸多维液体微乳及其制备方法
SG11201406208QA (en) 2012-05-03 2014-11-27 Janssen Sciences Ireland Uc Polyinosinic-polycytidylic acid (poly (i:c)) formulations for the treatment of upper respiratory tract infections
CN103599071B (zh) * 2013-11-08 2016-01-27 杭州美亚药业股份有限公司 一种双链聚肌胞干粉的制备方法
EP3083962B1 (en) * 2013-12-16 2021-08-18 RiboxX GmbH Double-stranded polyc:poly(g/i) rna for immunostimulation and cancer treatment
CN104434784B (zh) 2014-11-15 2017-07-04 成都天台山制药有限公司 聚肌胞注射液药物组合物和制法
CN105396130A (zh) 2015-11-10 2016-03-16 林海祥 皮氨钙佐剂及含有皮氨钙佐剂的疫苗
CN107184973A (zh) 2016-03-15 2017-09-22 中国医学科学院基础医学研究所 一种复合疫苗佐剂及其应用
CN106075431A (zh) 2016-03-23 2016-11-09 林海祥 皮氨钙联合佐剂及含有皮氨钙联合佐剂的疫苗
US10512687B2 (en) 2016-04-01 2019-12-24 Colorado State University Research Foundation Compositions and methods for enhanced innate immunity
CN107875168B (zh) * 2016-09-30 2022-03-04 广州百吉生物制药有限公司 一种免疫调节组合物在治疗恶性积液中的用途
RU2647366C1 (ru) 2017-04-12 2018-03-15 Федеральное государственное учреждение "Федеральный исследовательский центр "Фундаментальные основы биотехнологии" Российской академии наук" (ФИЦ Биотехнологии РАН) Антиагрегантное средство
CN109125264B (zh) 2017-06-19 2020-10-30 林海祥 一种抗感染抗肿瘤的粘膜免疫制剂
CN109078180B (zh) * 2018-06-29 2019-05-31 信福(北京)医药科技有限公司 用于增强免疫响应的复合物
JP7296644B2 (ja) 2018-06-29 2023-06-23 信福(北京)医▲薬▼科技有限公司 免疫応答を強化するための複合物の調製方法
CN108743938B (zh) 2018-06-29 2019-04-09 信福(北京)医药科技有限公司 用于增强免疫响应的复合物的制备方法

Similar Documents

Publication Publication Date Title
Zhang et al. Two-dimensional layered double hydroxide nanoadjuvant: recent progress and future direction
US20240398931A1 (en) Nucleic acid vaccines
ES2744491T3 (es) Procedimientos y composiciones para el tratamiento de la inflamación
CN105451743B (zh) 用于在活体中递送RNAi触发子至肿瘤细胞的聚偶联物
CN105873613A (zh) 用于核酸和药物递送的新型plga-修饰的聚乙烯亚胺自组装纳米技术
US20220162382A1 (en) Production of nanoparticles and microparticles
US20240398918A1 (en) Design of immunostimulatory protein-core spherical nucleic acids
Chen et al. Biodegradable hybrid recombinant block copolymers for non-viral gene transfection
JP2022062175A (ja) 免疫応答を誘導するための方法および手段
JP2022500444A (ja) クリグラー−ナジャー症候群の治療のためのウリジン二リン酸グリコシルトランスフェラーゼ1ファミリー、ポリペプチドa1をコードするポリヌクレオチド
CN108126210B (zh) 一种单靶向还原响应囊泡纳米药物在制备脑肿瘤治疗药物中的应用
CN106890336B (zh) 一种siRNA药物载体聚合物及其制备方法和在siRNA靶向输送中的应用
CN114615986A (zh) 具备cGAS-STING通路激活功能的纳米颗粒及其制备方法和应用
KR102631084B1 (ko) 면역 반응 증강용 복합체
JP2026506536A (ja) 核酸ベースのがんワクチンおよびその方法
CN110974962B (zh) 肿瘤免疫凝胶制剂的合成方法
RU2021101242A (ru) Комплекс для усиления иммунного ответа
CN111514289A (zh) 新冠病毒免疫纳米颗粒制剂的合成方法
CN116807973B (zh) 一种可调控pKa的纳米分子伴侣体系及其制备和应用
RU2779622C2 (ru) Комплекс для усиления иммунного ответа
CN115197157B (zh) 还原响应型的核酸递送载体及其制备方法、应用
KR102035696B1 (ko) 사이티딘 5-삼인산 또는 이의 고분자를 유효성분으로 포함하는 핵 내로의 약물 전달용 조성물 및 면역 증강제
JP2011512353A (ja) 天然インターフェロン・アルファ種に対する粘膜曝露による、宿主防御機構の遺伝子制御
Kim et al. Receptor‐Mediated Gene Delivery Using Chitosan Derivatives in Vitro and in Vivo
CN120393032A (zh) 一种工程化类脂转运蛋白用于高效疏水药物递送的载体及其制备方法与应用